Member Info for oxygen

Well worth a listen. All very positive with looking to achieve a $650m Revenue target in 5 yrs, with reliance on their previous largest customer ( Apple ) now insignificant (circa $10m down from $100m ) . With no debt and cash flow positive with Management holding around 25% of Stock can expect a progressive dividend policy, with VLX being heavily involved in some growth markets, including EV’s. One to hold onto.

Fingers crossed then ...this should warrant an RNS on Monday from someone !

Yep, there’s a huge number of 6 figure Salaries in the City trading rooms that need to be paid for .... ...bulk of that money coming from the likes of you and me !

Dramatic global news events can and do change investment sentiment dramatically and far more so than an individual Company’s good story. For that reason many seasoned investors will reduce their exposure whilst trading is closed, hence a Friday sell off is quite normal. The world is not exactly a peaceful place right now, is it ! Always only hold what you can afford to lose.

If you’ve the time and inclination this is a great Day Traders share. Frankly I don’t have either , so I just keep it simple, and buy. One day I may sell .....but it won’t be Avacta !

target Companies with a large retail investor base knowing how easy it is to influence the nervous and often poorly informed investor, many over exposed to their financial situation. It generates somewhat of a dubious fan base for them, as they indicate superior knowledge when frankly nothing could be further from the truth. Follow them at your peril, they won’t be remotely interested in your own well being.

That’s a strong set of results released today with dividend looking secure given revenue up to May this year, already 4% ahead. Nice one.

Seems some here need to sell up and move on as clearly don’t understand what the cornerstones of this Company are...it’s certainly not the LFT, albeit the hype around that has enabled AS to place the Company on a more secure financial position.

This guys time is currently very precious and I just hope he now gets on with the day job. Shareholders just need to be patient....few other CEO’s spend any time at all bothering to talk with stakeholders, unless they need more cash, so we can be grateful he’s of different mind. Personally would be surprised if the Cytiva antigen test appears before the end of July .......frankly I’m not in the least bit concerned, that's not the real gem here. I continue to accumulate.

Seems many thought the Cytiva Antigen Test would be ready to go to market mid June....it won’t be.

the hype around the Covid Test achieved its aim of getting the Fund Raise away, as this Company
was never going to be built on this short lived opportunity and that was quite evident from todays presentation and the time devoted to whats in the pipeline. Guess this will now throw off many short term traders who were expecting news within days, as clearly we are still weeks away from getting that product into market, but for LTH’s with a 2/3 yr horizon, that won’t be an issue.

Those at MS need to speak with their mates across at JPMorgan would came out with a possible Oil Price of $190 by 2025, only in March this year. And to think Institutions pay good money for such research !

Yes, given the circumstances this is a credible deal and removes a good deal of uncertainty. Well done TD.

I’m beginning to really like AB..... "With the strong performance in the year to date and continued focus on delivering our cost programme, we expect that for the remainder of the year we need to realise an average oil price of around $25/Boe to achieve free cash flow breakeven, and remain confident in meeting our targets."......thats good enough for me.

Winning this award really is a major victory for the Company. There is a huge market out there for water analytical equipment across the industrial landscape, an obvious example being food & drink manufactures, and having the ‘best in class’ on a global scale is a real bonus. A quick search indicates that these units retail at over $25,000 each, so a good source of revenue, plus recurring income from the supply of reagents. Can’t see this share now hanging around too long at this level.

As an existing Non Exec Director, now promoted as Chairman, I suspect he voted with the rest of them to cancel the divi. so wouldn’t hold out too much hope ! Lets hope he brings some much needed drive back into the job !

to all holders, you deserve this bounce for loyalty shown. May just be the beginning of a much needed upswing for you. GLA

Well if you’re prepared to wait up to 8 months thats your choice, personally I’m not. In my world cash & customer is king, and if you can’t supply it quickly enough I’ll go elsewhere......plenty to choose from these days.

BT.....Goldman Sachs slapping a 23p price target on this yesterday won’t help, as unfortunately they have rather more clout than any of us put together. GL.

Thats why they are moving to a ‘ build to order model’ but even that has issues. My last ‘ built to order ‘ special, took several months to appear and not without much complaining, indeed to the point I won’t bother next time. Its a tricky conundrum for them.